Market Access European biopharma at a crossroads If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.
Market Access Sustaining the mature product portfolio through strategic ou... Globalisation and the growth of emerging markets has created new opportunities to expand the reach for the mature portfolio.
R&D Driving innovation through partnership at AstraZeneca, with ... Nikhil Mutyal, head of search and evaluation for respiratory and immunology at AstraZeneca, discusses partnership and external innovation at LSX.
Oncology How can an engineering background change the approach to dev... Sometimes all it takes to make a breakthrough in research, in any field, is to look at the problem differently than anybody has before.
Sales & Marketing Biopharma's costly blind spot: Exhausted minds, expensive mi... Burnout isn't just a personal issue anymore; it’s a strategic imperative.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.